Clinical Trial Update: Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen

View source ↗

Summary

This completed clinical trial characterizes the adherence level required to achieve HIV viral suppression with a lopinavir/ritonavir (Kaletra)-based regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Montefiore Medical Center | Conditions: HIV Infection | Status: COMPLETED